The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trends in pegfilgrastim average sales price and cost-effectiveness of primary prophylaxis for patients at intermediate risk for febrile neutropenia.
 
Edward C. Li
Employment - Sandoz
Stock and Other Ownership Interests - Novartis
 
Kimberley J. Campbell
Employment - Sandoz-Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Bridgette Kanz Schroader
Employment - Xcenda
 
David Campbell
Employment - Curta Consulting
Research Funding - Xcenda
 
Stephen Chaplin
Employment - Xcenda
Research Funding - Sandoz (Inst)
 
Gary H. Lyman
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; E.R. Squibb Sons, LLC; G1 Therapeutics; Jazz Pharmaceuticals; MSD; Partner Therapeutics; Samsung Bioepis; Sandoz; Seagen
Research Funding - Amgen (Inst)